High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: pilot study.

Source:http://linkedlifedata.com/resource/pubmed/id/8888813

Download in:

View as

General Info

PMID
8888813